ScreenerHero
EXEExtendicare Inc.
TSX · CA · Healthcare · Medical Care Facilities · extendicare.com
30.94CAD-1.43%Mkt Cap: 2.17B $P/E: 24.15

Extendicare Inc., through its subsidiaries, provides care and services for seniors in Canada. It operates through the Long-term Care, Home Health Care, and Managed Services segments. The company offers long-term care ser…

Industry Peers

Medical Care Facilities
Screen all
HCA
HCA Healthcare, Inc.
$90.30BUSDP/E 13.7
FRE
Fresenius SE & Co. KGaA Inhaber-Aktien o.N.
$28.29BUSDP/E 16.7
THC
Tenet Healthcare Corporation
$21.62BUSDP/E 10.4
FME
Fresenius Medical Care AG & Co. KGaA
$11.94BUSDP/E 12.3
EHC
Encompass Health Corporation
$12.01BUSDP/E 20.3
DVA
DaVita Inc.
$11.38BUSDP/E 15.0
ENSG
The Ensign Group, Inc.
$10.64BUSDP/E 28.6
UHS
Universal Health Services, Inc. Class B
$10.16BUSDP/E 7.0
PACS
PACS Group Inc.
$7.01BUSDP/E 25.9
CHE
Chemed Corporation
$7.00BUSDP/E 26.9
LFST
LifeStance Health Group Inc. Common Stock
$4.90BUSDP/E 98.7
CON
Concentra Group Holdings Parent Inc. Common Stock
$4.43BUSDP/E 22.4
MCOV-B
Medicover AB (publ)
$3.49BUSDP/E 39.0
NHC
National HealthCare Corporation
$3.67BUSDP/E 26.3
OPCH
Option Care Health, Inc.
$3.50BUSDP/E 17.7
BKD
Brookdale Senior Living Inc.
$2.89BUSD
AVAH
Aveanna Healthcare Holdings Inc.
$2.87BUSDP/E 10.4
EMEIS
Emeis SA
$2.46BUSD
ACHC
Acadia Healthcare Company, Inc.
$2.55BUSD
GRDN
Guardian Pharmacy Services Inc. Class A Common Stock
$2.41BUSDP/E 36.5

Key Statistics

Company
Market Cap2.17B $
Enterprise Value2.52B $
Revenue (TTM)1.44B $
Gross Profit208.90M $
Net Income (TTM)70.39M $
Revenue/Share15.85 USD
Last Price30.94 CAD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees—
CountryCA
SectorHealthcare
IndustryMedical Care Facilities
ISINCA30224T8639
Valuation
P/E (Trailing)24.15
P/E (Forward)18.82
PEG—
EV/EBITDA16.66
EV/Revenue1.75
P/S1.47
P/B7.17
EPS (TTM)1.30
EPS (Forward)1.62
52W Range
12.6469% of range39.14
52W High39.14 CAD
52W Low12.64 CAD
Profitability
Gross Margin14.50%
Oper. Margin8.55%
EBITDA Margin10.48%
Profit Margin5.82%
ROE25.89%
ROA9.06%
Growth
Revenue Growth59.40%
Earnings Growth-14.50%
Cash Flow & Leverage
Operating CF119.14M $
CapEx (TTM)43.63M $
FCF Margin7.97%
FCF Yield5.29%
Net Debt402.21M $
Net Debt/EBITDA2.66
Balance Sheet
Debt/Equity0.88
Current Ratio0.75
Quick Ratio0.66
Book Value/Sh4.259 CAD
Cash/Share0.9830 CAD
Dividends
Fwd Div Rate0.5300 CAD
Trail. Div Rate0.5120 CAD
Div. Yield1.69%
5Y Avg Yield5.41%
Payout Ratio39.23%
Ex-Div DateAug 31, 2026
Pay DateSep 15, 2026
Analyst Consensus
Rating1.4 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)39.83 CAD
Upside (mean)+28.7%
Target Range31.50 CAD – 45.00 CAD
CAD31.50+28.7% to meanCAD45.00
# Analysts9
Ownership
Shares Out.95.05M
Float93.86M
Insiders0.48%
Institutions43.73%
Short Interest
Short Ratio4.5d
Short % Out.1.78%
Shares Short2.49M
Short (prev mo.)1.19M
Technical
SMA 5035.08 (-11.8%)
SMA 20027.84 (+11.1%)
Beta1.16
S&P 52W Chg18.16%
Avg Vol (30d)499.95K
Avg Vol (10d)672.53K
Technical Indicators
RSI (14)30.4
MACD-1.1533
MACD Signal-0.6603
MACD Hist.-0.4930
BB Upper40.30 CAD
BB Middle35.15 CAD
BB Lower30.00 CAD
BB Width29.29%
ATR (14)1.282 CAD
Vol Ratio (20d)0.75x